BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Mesoblast

Mesoblast logo

Founded
2004
Geography
Australia based
Funding
$56.200 M

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC)
technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney
disease, orthopedic spine conditions, and cardiovascular disorders.

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet